The lack of response to Omalizumab in patients with severe asthma is associated with IgE receptor mutations.
Year: 2025
Type: conference-abstract
Source: European Respiratory Journal
Institutions: Sağlık Bilimleri Üniversitesi, Ministry of Health
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416635559
